Emulate, Inc.

Emulate, Inc. is a biotechnology company focused on Organ-on-a-Chip technology. This innovative approach utilizes human cell-based microphysiological systems to replicate organ functions, aiding in drug development, toxicology, and human health research. Founded in 2013 as a spin-out from Harvard University's Wyss Institute, Emulate commercializes technology developed by Donald Ingber and his team, following significant research on lung functions. The company's Human Emulation System includes Organ-Chips, which are microfluidic devices designed to mimic human organ structures and functions. Emulate offers a range of products, including validated Bio-Kits for various organs and hardware solutions like the Zoë Culture Module and the AVA™ Emulation System. With over 30 organ models, Emulate supports research across multiple fields, including cancer, neuroscience, and personalized medicine. The company also provides fee-for-service partnerships for advanced studies and collaborates with notable organizations such as Roche, Takeda, and the U.S. FDA, emphasizing its commitment to innovation and reducing animal testing in research.